Form 8-K - Current report:
SEC Accession No. 0001641172-25-014118
Filing Date
2025-06-06
Accepted
2025-06-06 17:19:55
Documents
13
Period of Report
2025-06-06
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41865
2 EX-16.1 ex16-1.htm EX-16.1 4164
  Complete submission text file 0001641172-25-014118.txt   214830

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vvos-20250606.xsd EX-101.SCH 3005
4 XBRL LABEL FILE vvos-20250606_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE vvos-20250606_pre.xml EX-101.PRE 22352
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3808
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39796 | Film No.: 251032071
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)